BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16237500)

  • 1. Generation of improved mucosal vaccines by induction of innate immunity.
    Lavelle EC
    Cell Mol Life Sci; 2005 Dec; 62(23):2750-70. PubMed ID: 16237500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate endogenous adjuvants prime to desirable immune responses via mucosal routes.
    Wang X; Meng D
    Protein Cell; 2015 Mar; 6(3):170-84. PubMed ID: 25503634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modes of Action for Mucosal Vaccine Adjuvants.
    Aoshi T
    Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel vaccine development strategies for inducing mucosal immunity.
    Fujkuyama Y; Tokuhara D; Kataoka K; Gilbert RS; McGhee JR; Yuki Y; Kiyono H; Fujihashi K
    Expert Rev Vaccines; 2012 Mar; 11(3):367-79. PubMed ID: 22380827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for optimizing targeting and delivery of mucosal HIV vaccines.
    Ahlers JD; Belyakov IM
    Eur J Immunol; 2009 Oct; 39(10):2657-69. PubMed ID: 19609978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunisation: adjuvants and delivery systems.
    Moyle PM; McGeary RP; Blanchfield JT; Toth I
    Curr Drug Deliv; 2004 Oct; 1(4):385-96. PubMed ID: 16305400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in adjuvants for vaccines against infectious diseases.
    O'Hagan DT; MacKichan ML; Singh M
    Biomol Eng; 2001 Oct; 18(3):69-85. PubMed ID: 11566599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
    Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
    Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal adjuvants.
    Harandi AM; Medaglini D
    Curr HIV Res; 2010 Jun; 8(4):330-5. PubMed ID: 20353395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery strategies to enhance mucosal vaccination.
    Chadwick S; Kriegel C; Amiji M
    Expert Opin Biol Ther; 2009 Apr; 9(4):427-40. PubMed ID: 19344280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern mucosal vaccines, adjuvants and microbicides.
    Cranage MP; Manoussaka M
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):21-3. PubMed ID: 19622054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving vaccines by incorporating immunological coadjuvants.
    Fraser CK; Diener KR; Brown MP; Hayball JD
    Expert Rev Vaccines; 2007 Aug; 6(4):559-78. PubMed ID: 17669010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal and pulmonary vaccine delivery using particulate carriers.
    Jia Y; Krishnan L; Omri A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational application of nanoadjuvant for mucosal vaccine delivery system.
    Dewangan HK
    J Immunol Methods; 2020; 481-482():112791. PubMed ID: 32387695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvants and delivery systems in veterinary vaccinology: current state and future developments.
    Heegaard PM; Dedieu L; Johnson N; Le Potier MF; Mockey M; Mutinelli F; Vahlenkamp T; Vascellari M; Sørensen NS
    Arch Virol; 2011 Feb; 156(2):183-202. PubMed ID: 21170730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immunity and new adjuvants.
    Mutwiri G; Gerdts V; Lopez M; Babiuk LA
    Rev Sci Tech; 2007 Apr; 26(1):147-56. PubMed ID: 17633299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal vaccine design and delivery.
    Woodrow KA; Bennett KM; Lo DD
    Annu Rev Biomed Eng; 2012; 14():17-46. PubMed ID: 22524387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.